July 2024 - HempWire

WednesdayJul 31, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Produces Notable Findings in Latest Weight Loss Study

Lexaria, a global innovator in drug delivery platforms, has released interim results from its WEIGHT-A24-1 animal study The study sought to explore the impact of its patented DehydraTECH technology on glucagon-like peptide-1 (“GLP-1”) drugs for the potential treatment of diabetes and weight loss, representing a major global market The first 28 days of dosing yielded positive results that Lexaria’s management described as “noteworthy” It also marked a significant milestone for the company and the first time it has used liraglutide in any of its GLP-1 studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery enhancement, just released interim…

TuesdayJul 30, 2024 10:00 am

Despite Industry Protests, Texas GOP Wants Intoxicating Hemp Banned

The consumable hemp industry in the state of Texas is valued at an estimated $8 billion. When legislators drafted a law to legalize hemp in 2019, they didn’t consider the fact that intoxicating hemp could find its way to the market. At the time of enactment, CBD was the most common compound derived from hemp. This compound is known for not inducing a high when ingested, and it possesses medicinal properties. However, the industry’s growth allowed for the proliferation of intoxicating hemp, which induces highs when consumed. Currently, intoxicating compounds derived from hemp that are made into products such as…

ThursdayJul 25, 2024 10:00 am

Supreme Court Ruling Could Set Precedent Regarding Hemp as RICO Case Review Concludes

The Supreme Court is expected to give a ruling on a case involving hemp. This is the first time since the 2018 Farm Bill was enacted that the court will be ruling on any hemp-related case. This farming measure federally legalized the sale and production of hemp and its derivatives. This bill distinguishes marijuana from hemp by categorizing hemp as cannabis that doesn’t contain more than 0.3% THC. THC is one of the two primary compounds found in marijuana plants, with the other being CBD. Unlike THC, however, CBD doesn’t induce a high when ingested. CBD is one of hemp’s…

WednesdayJul 24, 2024 9:00 am

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration

Age-related macular degeneration is a disease significantly impacting the quality of life, making it difficult for individuals to perform everyday activities such as reading, driving, and recognizing faces InMed is currently developing a pipeline of drugs, like INM-089, to treat diseases with a high unmet medical need Delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement in in vivo preclinical disease model Age-related macular degeneration (“AMD”) is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part of the retina, known as the macula. This disease significantly impacts the quality of life, making it…

TuesdayJul 23, 2024 10:00 am

Product from Hempcrete Aces Passes Fire-Resistance Testing

Hemp has various applications, with its stalk being made of fibers that are flexible and soft. Hurds, the plant’s woody inner core, are hard and rigid. Americhanvre, a company offering hemp-building solutions, recently passed a fire-resistance test for its product, Ereasy. The Ereasy system is a spray-on application kit that delivers hempcrete, which is a construction material that has been used in construction for centuries. For instance, hempcrete plaster was applied more than 1,000 years ago on the walls of Ellora Caves in India. The manmade caves are a World Heritage site and were cut into rock then plastered from…

MondayJul 22, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) to Validate Earlier Semaglutide Studies with Successful GLP-1-H24-2 Study Dosing

Lexaria, a global innovator in drug delivery platforms, recently completed dosing of its human pilot study #2, GLP-1-H24-2 The study is to explore the tolerability, side effects, and blood levels of semaglutide, a glucagon-like peptide-1 (“GLP-1”) drug For Lexaria, the results from this study look to validate earlier studies that have demonstrated improvements in the delivery of semaglutide into the bloodstream Results from the GLP-1-H24-2 study are set to be announced in late August or early September Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced the dosing completion of its human pilot study #2, GLP-1-H24-2.…

ThursdayJul 18, 2024 10:00 am

WhatsApp Messages Suggest Florida GOP, DeSantis, Hemp Industry Teaming Up to Defeat Cannabis Legalization

The Office of the Governor of Florida has denied allegations about having an exchange agreement with hemp operators in the state. This comes after the state’s hemp industry pledged a $5 million donation to the state’s GOP party after Governor Ron DeSantis vetoed a measure that would have put a stop to the state’s intoxicating products. According to a popular news outlet, WhatsApp messages from Save Florida Hemp were leaked. This group includes hemp manufacturers, major laboratories and small shops. Hemp industry lobbyists in the state of Florida include Bill Helmin, the executive director of the party, and Evan Power,…

WednesdayJul 17, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Issuance of Three New Patents, Growing Portfolio to 46 Granted Patents Worldwide

Considered intangible assets, patents offer a significant competitive advantage and value for companies Lexaria Bioscience views its growing patent portfolio as a solid foundation upon which to build future commercial partnerships The company recently announced the receipt of three new patents in the E.U., Canada, and the U.S. The issuance of the latest three patents grows Lexaria’s patent portfolio to 46 granted patents worldwide Lexaria’s multi-patented DehydraTECH(TM) “drug delivery platform technology” offers proven increased bioavailability, enhancing the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery, helping with speed of onset, and brain absorption of…

TuesdayJul 16, 2024 10:00 am

New Hemp Reference Material from NIST to Ensure Accuracy in Cannabis Measurement

Earlier this week, the National Institute of Standards and Technology (NIST) announced that it was selling reference material on hemp that would assist labs in correctly measuring components in products made from the cannabis plant. The reference material was made from commercially purchased dried hemp, which the researchers ground, sieved, blended and measured to a high degree of precision and accuracy. Each unit includes three packets with 1.5 grams of ground hemp. This material will also help agencies of law enforcement accurately differentiate between marijuana and hemp, given that both come from the cannabis plant. Prior to the legalization of…

MondayJul 15, 2024 10:30 am

Golden Triangle Ventures Inc. (GTVH), Lavish Entertainment Report on Progress of One-of-a-Kind Entertainment Destination

New project “set to transform luxury entertainment and hospitality,” according to company officials Critical development has included work on infrastructure and improvements Officials also focused on obtaining required permits, assembling key leadership and identifying ideal vendors A luxury destination featuring world-class entertainment, opulent accommodations and immersive experiences is rising in the Mojave Desert. The unique property, called Destino Ranch, is a bold, visionary project envisioned by Golden Triangle Ventures (OTC: GTVH) and its wholly owned subsidiary, Lavish Entertainment. Golden Triangle and Lavish Entertainment recently provided an update (https://cnw.fm/Rfq7n) on the one-of-a-kind project, which is “set to transform luxury entertainment and hospitality.” According to…

News and publishing service for hemp related companies

Contact us: 303.498.7722

Month: July 2024